Horizon Global Corp. (HZN): Price and Financial Metrics
HZN Price/Volume Stats
|Current price||$1.76||52-week high||$7.20|
|Prev. close||$1.76||52-week low||$0.30|
|Day high||$1.76||Avg. volume||656,808|
|50-day MA||$1.15||Dividend yield||N/A|
|200-day MA||$1.55||Market Cap||48.81M|
HZN Stock Price Chart Interactive Chart >
Horizon Global Corp. (HZN) Company Bio
Horizon Global Corporation is a leading designer, manufacturer and distributor of industry leading high-quality, custom-engineered towing, trailering, cargo management and related accessory products for original equipment, aftermarket and retail channel customers on a global basis. The company operates independently of TriMas Corporation as of June 30, 2015.
HZN Latest News Stream
|Loading, please wait...|
HZN Latest Social Stream
View Full HZN Social Stream
Latest HZN News From Around the Web
Below are the latest news stories about HORIZON GLOBAL CORP that investors may wish to consider to help them evaluate HZN as an investment opportunity.
PLYMOUTH, Mich., February 08, 2023--First Brands Group Completes Acquisition of Horizon Global Corporation
PLYMOUTH, Mich., February 07, 2023--First Brands Group and Horizon Global Corporation Announce Expiration of Tender Offer
As of Wednesday, Horizon Global Corporation’s (NYSE:HZN) stock closed at $1.73, down from $1.74 the previous day. While Horizon Global Corporation has underperformed by -0.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HZN fell by -79.18%, with highs and lows ranging from $8.27 to $0.30, […]
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday''s Mid-Day Session
Gainers Horizon Global Corporation (NYSE: HZN ) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. Jasper Therapeutics, Inc. (NASDAQ: JSPR ) gained 257% to $1.70 after the company announced clinical data from a Phase I/II trial of briquilimab as a conditioning treatment in sickle cell disease and beta thalassemia. ReShape Lifesciences Inc. (NASDAQ: RSLS ) shares jumped 142.3% to $16.34. Reshape Lifesciences recently announced a 1-for-50 reverse stock split. Lucira Health, Inc. (NASDAQ: LHDX ) surged 68% to $0.1875 after the company announced it submitted an Emergency Use Authorization application to the FDA for OTC use of its COVID-19 & Flu test. Swvl Holdings Corp. (NASDAQ: SWVL ) shares gained 43% to $0.1958 after the company reported ...
Full story available on Benzinga.com
HZN Price Returns